ABOUT US
SIMPLIFYING CHRONIC CARE

Jake has a unique combination of biomedical engineering experience and entrepreneurial acumen. He holds a B.S. of Biomedical Engineering from Union College and an M.Sc. of Innovation and Management from Tufts University. He couples this with leadership qualities developed over a lifetime of team sports to help set the direction of Anodyne.

Konstantinos is an engineer turned entrepreneur. He holds a Diploma in Electrical and Computer Engineering from National Technical University of Athens and an M.Sc. in Innovation and Management from Tufts University, Boston, USA. Konstantinos has engineering and management expertise coupled with exposure in the US and Greece, making the alignment of interdisciplinary teams second nature.

Hojat is a Physicist specialized in Microscale and Nanoscale physics. His work led to the discovery of several new physics that describe the behavior of nano-bubbles (NBs) and nano-droplets (NDs) in nanoscale and particles in microscale.

Dr. Nejad is also a known specialist in Micro/Nano Fabrication technologies. His work resulted in the development of innovative biomedical and lab-on-chip drug delivery and diagnostic devices. He is a former Assistant Professor of electrical and computer engineering at Tufts University was also a Pre- and Post-doctoral research fellow at Harvard-MIT Division of Health Sciences and Technology (HST). Dr. Nejad is a winner of several prestigious awards including Friedman Foundation Scholarships in Health Sciences. Dr. Nejad is from Shiraz, Iran.

Experienced Chief Operating Officer in scaling Medical Device and Biotech start-ups, guiding them from concept to GMP manufacturing for clinical trials and commercialization. Prior to his entrepreneurial ventures, Michael held key leadership roles at BD (Becton Dickinson), across 8 locations and 6 business units. His work included driving successful product launches of devices and instruments that are currently used worldwide to deliver healthcare as well as stewardship with overseeing global production volumes ranging from hundreds of millions to billions annually. Michael holds an MBA from MIT and a Mechanical Engineering Degree from BYU.

Chirag is a results-oriented leader with significant experience in R&D, Product Development, Quality and Operations. He has held various leadership positions at Arch Therapeutics, Medtronic (Covidien), Biolink and C.R. Bard.  He has an excellent record in establishing collaborations and fostering innovative customer focused teams. Dr. Shah earned a PhD from University of Rhode Island and Executive Leadership Certificates from Cornell and MIT.